Original Research

How Effective Is Group Cognitive Behavioral Therapy to Treat PTSD?

Fed Pract. 2014 October;31(10):20-24

References

1. Litz B, Schlenger W. Posttraumatic stress disorder in service members and new veterans of the Iraq and Afghanistan wars: A bibliography and critique. PTSD Res Q. 2009;20(1):1-3.

2. Tanielian T. Assessing combat exposure and post-traumatic stress disorder in troops and estimating the costs to society: Implications from the RAND Invisible Wounds of War Study. http://www.rand.org/pubs/testimonies/CT321.html. Published 2009. Accessed September 29, 2014.

3. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.

4. Cukor J, Spitalnick J, Difede J, Rizzo A, Rothbaum BO. Emerging treatments for PTSD. Clinical Psychol Rev. 2009;29(8):715-726.

5. Hoge CW. Interventions for war-related posttraumatic stress disorder: Meeting veterans where they are. JAMA. 2011;306(5):549-551.

6. Veterans Health Administration, Department of Defense. VA/DoD Clinical Practice Guideline: Management of Post-Traumatic Stress, Version 2.0. Washington, DC: Veterans Health Administration and Department of Defense; 2010.

7. Burlingame GM, Fuhriman A, Mosier J. The differential effectiveness of group psychotherapy: A meta-analytic perspective. Group Dyn. 2003;7(1):3-12.

8. Barrera TL, Mott JM, Hofstein RF, Teng EJ. A meta-analytic review of exposure in group cognitive behavioral therapy for posttraumatic stress disorder. Clin Psychol Rev. 2013;33(1):24-32.

9. Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2007;(3):CD003388.

10. Khoo A, Dent MT, Oei TS. (2011). Group cognitive behaviour therapy for military service-related post-traumatic stress disorder: Effectiveness, sustainability and repeatability. Aust N Z J Psychiatry. 2011;45(8):663-672.

11. Swanson LM, Favorite TK, Horin E, Arnedt JT. A combined group treatment for nightmares and insomnia in combat veterans: A pilot study. J Trauma Stress. 2009;22(6):639-642.

12. Erickson DH, Janeck A, Tallman K. A cognitive-behavioral group for patients with various anxiety disorders. Psychiatr Serv. 2007;58(9):1205-1211.

13. Thompson AR, Wilde E, Boon K. The development of group CBT for the treatment of road-traffic-accident-related post-traumatic stress disorder: A pilot study. Cognitive Behav Therapist. 2010;2(1):32-42.

14. Slade T, Johnston A, Oakley-Browne MA, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: Methods and key findings. Aust N Z J Psychiatry. 2009;43(7):594-605.

15. Crowe TP, Grenyer BF. Is therapist alliance or whole group cohesion more influential in group psychotherapy outcomes? Clin Psychol Psychother. 2008;15(4):239-246.

16. Leszcz M, Kobos JC. Evidence-based group psychotherapy: Using AGPA’s practice guidelines to enhance clinical effectiveness. J Clin Psychol. 2008;64(11):1238-1260.

Current research has demonstrated a solid base from which to spawn specific treatment protocols. The available research is investigational in terms of treatment procedures. Replication of these studies could dictate treatment protocol and contribute substantively to future VA and DoD CPG updates. Future researchers should consider the use of a standard PTSD symptom assessment tool to make interstudy comparisons more meaningful. The length of treatment and exposure elements should be targeted specifically in future research as these components currently vary the most.

The military represents an obvious avenue for future research due to increased PTSD diagnosis in recent years. Although the etiology of the increase in PTSD is unclear and most likely multifactorial (decreased resilience, increased awareness, increased pursuit of secondary gains, etc), the need for treatment options is apparent.¹ Group cohesion has been shown to be a core component of successful group psychotherapy, so military members who are accustomed to unit cohesion might represent a uniquely suitable population for this modality.¹⁵ Interestingly and for reasons not currently understood, veterans do not see effects of therapy as large as their civilian counterparts.⁸ This underscores the need for further evaluation of military-specific outcomes.

CONCLUSIONS

Although the available evidence is not robust, results do support the careful use of GCBT as an effective treatment for PTSD symptom reduction.⁸ Group psychotherapy has been generally regarded as an efficacious and cost-effective method to achieve similar outcomes to individual therapy. Increasing PTSD prevalence compels mental health care providers to explore all available treatment options. The potential for GCBT as an option is exciting, especially for mental health providers and those with limited resources. Rising health care standards and the current national fiscal situation is dictating a reevaluation of treatment options; so perhaps all health care providers will soon consider the use of GCBT.

As with any group assignment, the clinician should carefully consider the individual’s suitability and desire for group participation.¹⁶ With GCBT, providers could facilitate the relief of relentless apprehension and functional impairment for several patients simultaneously. Although there are many details left to explore regarding the use of GCBT for PTSD, the therapy’s foundation for use as a PTSD treatment is apparent.

Author disclosures
The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.